INTRODUCTION
============

The respiratory system is continuously exposed to foreign antigens from either airborne or commensal microbes. Due to vulnerability of the physical epithelial barrier of the respiratory system, most pathogens are stopped from entering the body by the mucosal immune system. A key component of the airway mucosal immune system that prevents microbial infections and colonization is secretory IgA (S-IgA), which is composed of dimeric IgA produced in the lamina propria and extracellular part of the polymeric immunoglobulin receptors (pIgR), also known as the secretory component (SC) expressed by mucosal epithelial cells ([@b6-ZoolRes-38-1-44]).

Newly synthesized pIgR is localized to the basolateral surfaces of mucosal epithelial cells, where it binds to dimeric IgA (dIgA) and mediates transcytosis of IgA to the apical surface of the epithelial cells ([@b7-ZoolRes-38-1-44]). The SC can be released to the mucosal surface alone (in the absence of IgA) or together with dIgA as S-IgA. In addition, SC bound to dIgA can elongate the life of S-IgA and enhance its immune exclusion ability. It can also stop microbial invasion. Mice deficient in pIgR expression are reportedly unable to control infections of the airway by some bacteria, which could drive progressive chronic obstructive pulmonary disease (COPD) phenotype in these mice ([@b12-ZoolRes-38-1-44]).

Pulmonary complications are common and major causes of morbidity and mortality in HIV-infected individuals, even in the presence of highly active antiretroviral therapy (ART) ([@b3-ZoolRes-38-1-44]; [@b9-ZoolRes-38-1-44]). Increased pulmonary infections and microbial colonization are common in HIV/AIDS patients ([@b15-ZoolRes-38-1-44]). Whether and how the S-IgA/pIgR system is involved in these alterations is not well addressed. Rhesus macaques are important in HIV/AIDS studies. In previous research, we found that pIgR expression was altered in the gut mucosa of SHIV/SIV-infected rhesus macaques ([@b14-ZoolRes-38-1-44]). To determine whether pIgR is involved in the respiratory pathology of HIV/AIDS, we examined the expression of pIgR in the tracheal mucosa of SHIV/SIV-infected rhesus macaques.

MATERIALS AND METHODS
=====================

Tissues
-------

Tissue samples from the tracheas and lungs were collected from five normal and five SHIV/SIV-infected rhesus macaques (*Macaca mulatta*), as reported previously ([@b14-ZoolRes-38-1-44]). The sites from which samples were collected were chosen randomly. Tissue samples for RNA isolation were frozen on dry ice immediately after collection and preserved in a freezer at -80 ℃ before use. Tissue samples for confocal microscopy were fixed in 4% paraformaldehyde immediately after collection, then washed and protected with 30% sucrose, and finally embedded in OCT and preserved in a freezer at -80 ℃. All study animals were treated humanely per the state and local regulations on the care and use of experimental animals.

Real-time RT-PCR
----------------

Quantification of pIgR and IL-17A mRNA levels was conducted by TaqMan® probe real-time RT-PCR, as performed previously ([@b14-ZoolRes-38-1-44]; [@b16-ZoolRes-38-1-44]). Briefly, RNA was isolated using a RNAprep Pure Tissue Kit (Tiangen Biotech, China) per the manufacturer\'s protocols. Real-time PCR mixtures were established with a One Step PrimeScript® RT-PCR Kit (Takara, Japan) and primers and probes for pIgR and IL-17A ([@b14-ZoolRes-38-1-44]; [@b16-ZoolRes-38-1-44]). PCR was performed on a 7500 Real-Time PCR System with 7500 System SDS software version 1.4 (ABI, USA). GAPDH mRNA levels in all samples were used as internal controls.

Confocal microscopy
-------------------

Tissue sections were cut with a cryostat LEICA CM 1850 (Leica Inc., Germany) to a thickness of 20 microns. After removing the OCT with PBS supplemented with 0.1% Triton X-100 and FSG, the slides were washed with PBST and blocked with 10% normal goat serum for 1 h before incubation in polyclonal antibody against human pIgR (rabbit anti-PIGR, 4 µg/mL, Abcam, USA) at 4 ℃ overnight. Sections were incubated in secondary antibody (Alexa Fluor 488 conjugated goat anti-rabbit IgG, 2 µg/mL, Invitrogen, USA) for 1 h after washing off the extra primary antibody. Slides were washed and mounted with anti-fade mounting medium and observed with an Olympus FV1000D-ST confocal microscope (Olympus, Japan). Images (1024×1024) were acquired and morphometric measurements were obtained with Image-Pro Plus software version 6.0 (Media Cybernetics, Silver Springs, MD, USA).

Statistics
----------

All quantitative parameters were expressed as mean ± *SD*. Non-parametric Mann-Whitney *U* test was used to compare the means of parameters between normal and infected rhesus macaques. Spearman test was used to calculate the correlations between pIgR mRNA and IL-17A mRNA levels. *P* values of less than 0.05 were considered statistically significant.

RESULTS
=======

Localization of pIgR immunoreactivity in the tracheal mucosa of rhesus macaques
-------------------------------------------------------------------------------

To detect the expression of pIgR in the tracheal mucosa of rhesus macaques, pIgR immunoreactive cells were examined with confocal microscopy. As shown in [Figure 1](#F1-ZoolRes-38-1-44){ref-type="fig"}, pIgR immunoreactivity was detected with a polyclonal antibody against human pIgR. In the epithelium, immunoreactivity to pIgR was localized to both the apical and basolateral surfaces of the epithelial cells. It was also localized in the cytoplasm of the basal part (under the nucleus) of the epithelial cells. After SHIV/SIV infection, pIgR immunoreactivity was lower in the tracheal mucosa of rhesus macaques.
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Expression of pIgR decreased in the tracheal epithelium of SHIV/SIV-infected rhesus macaques
--------------------------------------------------------------------------------------------

To determine changes in pIgR expression after SHIV/SIV infection, levels of pIgR immunoreactivity were quantitatively examined with Image-Pro Plus software and pIgR mRNA levels were examined by real-time PCR. As shown in [Figure 2](#F2-ZoolRes-38-1-44){ref-type="fig"}, levels of pIgR immunoreactivity were 1.65 times higher in the tracheal epithelium of normal rhesus macaques than that in SHIV/SIV-infected rhesus macaques ([Figure 2A](#F2-ZoolRes-38-1-44){ref-type="fig"}), with statistical significance (Mann-Whitney *U* test, *P*=0.007 9). The transcription levels of pIgR genes in the tracheal mucosa of normal rhesus macaques were 1.57 times higher than that in infected rhesus macaques, although the difference was not statistically significant (Mann-Whitney *U* test, *P*=0.254 4). Therefore, both the transcription and protein levels of pIgR were about 1.6 times higher in normal than in infected rhesus macaques.
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IL-17A is a regulator of pIgR expression and is decreased in HIV and SIV infection. We examined the transcription levels of IL-17A in the tracheal mucosa of normal and infected rhesus macaques. IL-17A mRNA levels in the tracheal mucosa of normal rhesus macaques were 1.8 times higher than that in SHIV/SIV-infected rhesus macaques ([Figure 2C](#F2-ZoolRes-38-1-44){ref-type="fig"}), although the difference did not reach statistical significance (Mann-Whitney *U* test, *P*=0.5476). Positive correlation was observed between pIgR and IL-17A mRNA levels in the tracheal mucosa of normal rhesus macaques ([Figure 2D](#F2-ZoolRes-38-1-44){ref-type="fig"}), though this trend was not found in SHIV/SIV-infected rhesus macaques.

Expression of pIgR in the lungs of SHIV/SIV-infected rhesus macaques
--------------------------------------------------------------------

To determine whether the lungs of SHIV/SIV-infected rhesus macaques were similarly affected, the expressions of pIgR mRNA and IL-17A mRNA in the lungs of normal and infected rhesus macaques were examined. The mRNA levels of pIgR and IL-17A were 50 and 32 times higher, respectively, in the tracheal mucosa than in the lungs. As shown in [Figure 3](#F3-ZoolRes-38-1-44){ref-type="fig"}, pIgR and IL-17A mRNA were both detected in the lungs of normal and infected rhesus macaques. In contrast to the changes observed in the tracheal mucosa, the levels of pIgR and IL-17A mRNA were 3 and 1.2 times higher, respectively, in infected rhesus macaques than in normal rhesus macaques, although the differences were not statistically significant (Mann-Whitney *U* test, *P*=0.4396 and 0.7857, respectively). Therefore, the expressions of pIgR and IL-17A were higher in the tracheal mucosa than in the lungs, and were not reduced in the lungs of SHIV/SIV-infected rhesus macaques.
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DISCUSSION
==========

In the present study, we observed reduced expression of pIgR in the tracheal mucosa of SHIV/SIV-infected rhesus macaques. Both the protein levels and mRNA levels of pIgR were decreased to almost the same degree, although the decrease in protein levels was statistically significant, whereas that of mRNA was not. It is possible that the effects of SHIV/SIV infection on pIgR expression were at the gene transcription level. In consistent with these results, previous research showed that pIgR mRNA levels were significantly reduced in the intestinal mucosa of SHIV/SIV-infected rhesus macaques ([@b14-ZoolRes-38-1-44]). Downregulation of pIgR in airway mucosa has also been documented in other airway diseases ([@b2-ZoolRes-38-1-44]; [@b4-ZoolRes-38-1-44]). Since the pathology between SIV and HIV infection is similar, pIgR expression in the airway mucosa of HIV-infected patients could also be significantly affected.

The mechanism of decreased pIgR expression in SHIV/SIV infection has not been addressed. There are many potential factors that could affect pIgR expressiopn, among which IL-17A can significantly regulate pIgR expression ([@b5-ZoolRes-38-1-44]). In the present study, a decrease in IL-17A expression in the tracheal mucosa of infected rhesus macaques was observed, suggesting a role of IL-17A in the downregulation of pIgR expression in the context of SHIV/SIV infection. The non-significant difference might be due to the large individual variability and small sample size. Significant correlation between pIgR and IL-17A mRNA has been observed in the intestinal mucosa of these animals and a significant decrease in IL-17A mRNA has also been observed in the intestinal mucosa ([@b14-ZoolRes-38-1-44]; [@b16-ZoolRes-38-1-44]). Further studies are warranted to reveal the mechanism underlying the decrease of pIgR expression in HIV/AIDS.

The consequence of reduced pIgR expression in the tracheal mucosa of SHIV/SIV-infected rhesus macaques is unknown. Nevertheless, these data indicate impaired immune exclusion of potential pathogenic and commensal microbes in the respiratory system. In line with this, increased airway microbes and pulmonary infections have been documented in HIV/SIV infections ([@b10-ZoolRes-38-1-44]; [@b13-ZoolRes-38-1-44]). Since elevated microbes can drive the COPD-like phenotype in pIgR deficient mice ([@b12-ZoolRes-38-1-44]) and downregulation of pIgR is observed in COPD patients ([@b2-ZoolRes-38-1-44]), reduced pIgR expression could be an underlying mechanism of the increased incidence of COPD in HIV/AIDS patients ([@b8-ZoolRes-38-1-44]). COPD is the cause of death in a significant proportion of the HIV/AIDS population. ART treatment does not decrease the incidence of COPD, but is an independent predictor of increased airway obstruction ([@b1-ZoolRes-38-1-44]). Decreased expression of pIgR might also be involved in other pathological processes of HIV/AIDS, such as lung cancer ([@b11-ZoolRes-38-1-44]). Therefore, abnormal expression of pIgR should be taken into consideration in novel therapies for pulmonary complications such as COPD.

In summary, for the first time, reduced pIgR expression was observed in the tracheal mucosa of SHIV/SIV-infected rhesus macaques, which might be linked to IL-17A reduction in the tracheal mucosa. The reduced expression of pIgR might be the underlying mechanism of increased pulmonary microbiota and infections in HIV/AIDS. Rhesus macaques are a suitable model for future dissection of the mechanisms underlying respiratory complications in HIV/AIDS.
